PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $487,000 | -32.1% | 112,646 | -37.3% | 0.00% | – |
Q2 2019 | $717,000 | -29.8% | 179,639 | -5.7% | 0.00% | – |
Q1 2019 | $1,021,000 | +3.8% | 190,401 | -0.7% | 0.00% | – |
Q4 2018 | $984,000 | -47.1% | 191,779 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $1,860,000 | +145.7% | 191,779 | +553.1% | 0.00% | – |
Q2 2015 | $757,000 | -18.5% | 29,363 | -1.2% | 0.00% | -100.0% |
Q1 2015 | $929,000 | -35.8% | 29,729 | -20.8% | 0.00% | 0.0% |
Q4 2014 | $1,447,000 | – | 37,545 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
CM Management, LLC | 200,000 | $972,000 | 0.72% |
GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |